Trivolib DS 1mg/1000mg/0.2mg Tablet SR
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Glimepiride (1mg) + Metformin (1000mg) + Voglibose (0.2mg)
Overview Trivolib DS 1mg/1000mg/0.2mg Tablet SR
DiaBeta-Plus 1mg/1000mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose concentrations. Administer DiaBeta-Plus with food, consistently at the same time daily for optimal efficacy. Dosage will be determined and adjusted by your physician based on your blood sugar response. Continue this medication as directed, even if feeling well or achieving satisfactory blood glucose control. Premature discontinuation, without consulting your physician, risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices are crucial in diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to treat them. Maintain regular meals and always carry a fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to monitor blood cell counts and liver function.
Primary Ingredients of Trivolib DS 1mg/1000mg/0.2mg Tablet SR
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Trivolib DS 1mg/1000mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Trivolib DS 1mg/1000mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trivolib DS 1mg/1000mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet on an empty stomach.
Common Side effects of Trivolib DS 1mg/1000mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Trivolib DS 1mg/1000mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Trivolib DS 1mg/1000mg/0.2mg Tablet SR should be swallowed whole; do not chew, crush, or break it. Administer on an empty stomach.
How Trivolib DS 1mg/1000mg/0.2mg Tablet SR works:
The extended-release tablet, Trivolib DS, contains 1 mg, 1000 mg, and 0.2 mg of three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Trivolib DS 1mg/1000mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Trivolib DS 1mg/1000mg/0.2mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Trivolib DS tablets (1mg/1000mg/0.2mg) are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Trivolib DS 1mg/1000mg/0.2mg Tablet SR in individuals with kidney impairment carries a significant risk and is best avoided. Medical advice is essential. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Trivolib DS 1mg/1000mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Trivolib DS 1mg/1000mg/0.2mg Tablet SR :
Should you forget to take a Trivolib DS 1mg/1000mg/0.2mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Trivolib DS 1mg/1000mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently